Liraglutide
by Generic (Novo Nordisk formulation)
The affordable liraglutide option — same proven GLP-1 mechanism as Saxenda at a lower cost
8%
Average body weight loss vs placebo
SCALE Obesity trial, NEJM 2015
63%
Patients achieved ≥5% weight loss
SCALE Obesity trial, NEJM 2015
33%
Patients achieved ≥10% weight loss
SCALE Obesity trial, NEJM 2015
56 weeks
Pivotal trial duration
SCALE Obesity trial, NEJM 2015
Liraglutide is a GLP-1 receptor agonist that mimics the body's natural GLP-1 hormone. It reduces appetite, slows gastric emptying, and improves insulin secretion — leading to consistent caloric deficit and sustained weight loss over time.
Always follow your prescribing physician's specific instructions. The schedule below is a general guide.
Initiation dose — not intended for weight management at this level
First escalation — appetite reduction begins
Continued escalation
Near-therapeutic dose
Full maintenance dose — once daily injection
Seek immediate medical attention if you experience any serious adverse effects.
Starting from
$175.00
Reviewed by a licensed US physician
Average 21% body weight loss — the gold standard in medically supervised weight loss
Up to 22.5% body weight loss — the most effective weight loss medication in clinical history
Effective oral appetite control for patients who prefer tablets over injections
A licensed US physician will review your consultation, answer all your questions, and prescribe if you're eligible — all from the comfort of home.
No commitment · Reviewed within 24 hours · HIPAA-compliant